Scholars Central

Conference abstractPublished 21 Aug 2023

Drug safety through its development

Authors: Antonio Steardo

Sapienza University of Rome, Italy

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

By a side, genetic engineering raises several ethical questions on gene editing and manipulation. On the other hand, drug safety development should lead to assure pharmaceutical manufacturing gene engineering tools are safe as they are effective. Two steps seem to be important to obtain this feature. The first starts from in silico creating a target molecule. The second should combine the test on molecular mechanism in phase I and so on the evaluation of the bioengineered drug by phases II and III. Trail Safety as well as Efficacy must be the most important characteristic to assess. Along with these clinical processes in vivo, the study can be the first step to understanding the role of the bioengineered pharmaceutical tool in the mechanism. Safety and efficacy get close to those warnings about gene manipulation. They should be considered for what they generate properly.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Antonio Steardo”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels